Header links
Intranet
Donate now
image/svg+xml Map
Contact us

General finder

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

Year
2024
Data d'inici
Data de tancament
Grup de recerca
Gene and Cell Therapy
Descripció
Research position for gene and cell therapies in muscular dystrophy_20240252
Codi
2024-252
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0252//2024_0252_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Childhood Cancer and Blood Disorders
Descripció
Data manager
Codi
2024-250
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0250//2024_0250_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Administrative_20240251
Codi
2024-251
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0251//2024_0251_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
International Post-award Research Officer_20240247
Codi
2024-247
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0247//2024_0247_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Epidemiology and Public Health
Descripció
Research administrative support
Codi
2024-248
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0248//2024_0248_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Rheumatology
Descripció
IT Coordinator Rheumatology Group_20240249
Codi
2024-249
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0249//2024_0249_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Childhood Cancer and Blood Disorders
Descripció
Scientific Project Manager_20240242
Codi
2024-242
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0242//2024_0242_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Childhood Cancer and Blood Disorders
Descripció
ERN EuroBloodNet Projects Coordinator
Codi
2024-243
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0243//2024_0243_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Childhood Cancer and Blood Disorders
Descripció
Project Manager_Registries
Codi
2024-244
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0244//2024_0244_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Ethics Committees Administrative_20240245
Codi
2024-245
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0245//2024_0245_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Microbiome Research
Descripció
Research Technician Microbiome Research Group _20240246
Codi
2024-246
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0246//2024_0246_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Rheumatology
Descripció
Clinical Research Monitor Rheumatology Research Group _20240240
Codi
2024-240
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0240//2024_0240_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Basic, Translational and Clinical Pharmacy Research
Descripció
Call for Postdoctoral Junior Leader fellowships (Basic,Translational and Clinical Pharmacy Research Group)_20240241
Codi
2024-241
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0241//2024_0241_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Biddings Manager_20240239
Codi
2024-239
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0239//2024_0239_001.pdf
Reclutant
Inactiu

Estudio de extensión, abierto de 52 semanas para evaluar la pimavanserina en niños y adolescentes con irritabilidad asociada al trastorno del espectro autista (TEA)

Contact

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Estudio de fase 3, aleatorizado y controlado con placebo para evaluar la eficacia y la seguridad de MK-0616 para reducir las complicaciones cardiovasculares graves en participantes con riesgo cardiovascular elevado.

Contact
  • Protocol code: MK-0616-015
  • EudraCT code: No aplica
  • Pathology: Malalties del sistema circulatori
  • Principal investigator:  Lozano Torres, Jordi
  • Research group:  Malalties cardiovasculars
  • Service: Cardiologia
  • Phase: Fase III
  • Recruiting: Open
  • Status: Open

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

A Phase 1, Multicenter, Single-arm, Dose-escalation Study of CC-97540 (BMS-986353), CD19-Targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, Evaluating Safety and Tolerability in Participants with Relapsing Forms of Multiple Sclerosis (RMS) or Progressive Forms of Multiple Sclerosis (PMS) / Estudio fase I, multicéntrico, de brazo único, de aumento escalonado de la dosis de CC-97540 (BMS-986353), células T con receptor de antigénico quimérico (CAR-T) NEX-T dirigidas frente a CD19, para evaluar la seguridad y la tolerabilidad en participantes con formas recidivantes de esclerosis múltiple (EMR) o formas progresivas de esclerosis múltiple (EMP)

Contact

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Eficacia de duloxetina perioperatoria en pacientes con alto riesgo de desarrollar dolor crónico post-quirúrgico tras la cirugía de hernia inguinal: ensayo multicéntrico, aleatorizado y controlado

Contact
  • Protocol code: ICI21/00006l
  • EudraCT code: No aplica
  • Pathology: Factors que influencien en l’estat de salut i contacte amb els serveis de salut
  • Principal investigator:  Salgado Algaba, Inmaculada
  • Service: Anestèsia
  • Phase: Phase III
  • Recruiting: Closed
  • Status: Open

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

“Estudio aleatorizado, doble ciego, controlado con placebo y degrupos paralelos para evaluar la eficacia y la seguridad a largo plazo de dupilumab enniños de 2 a <6 años con asma no controlada y/o sibilancias asmáticas gravesrecurrentes

Contact
  • Protocol code: EFC14771
  • EudraCT code: No aplica
  • Pathology: Malalties del sistema respiratori
  • Principal investigator:  de Mir Messa, Inés
  • Research group:  Creixement i desenvolupament
  • Service: Pediatria General i Especialitats
  • Phase: Phase III
  • Recruiting: Open
  • Status: Open

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Estudio de extensión de fase IV, multicéntrico y abierto para pacientes con enfermedad de células falciformes que hayan completado un estudio anterior de crizanlizumab promocionado por Novartis

Contact

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.